2m 2m 2m 2m 2m 2m 2m
OCUGEN (OCGN)
NASDAQ
$1.25+$0.02 (+1.38%)
Price as of Aug 03, 2026 9:01 AM EDT- $416.4MMarket Cap
- 23.79%1-Year Change
- BiotechnologyIndustry
OCUGEN (OCGN)
$1.25+$0.02 (+1.38%)
OCGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.23 | ||
Change | -$0.03 (-2.38%) | ||
Open | $1.29 | ||
High | $1.30 | ||
Low | $1.23 | ||
Previous Close | $1.26 | ||
Volume | 4,149,005 | ||
30-Day Average Volume | 5,001,715 | ||
1-Week Change | 1.65% | ||
1-Month Change | -19.61% | ||
1-Year Change | 23.79% | ||
3-Year Change | 100.00% | ||
5-Year Change | -81.67% | ||
Fundamentals | |||
Shares Outstanding | 338.5M | ||
Total Assets | $56.9M | ||
Market Cap | $416.4M | ||
Enterprise Value | $413.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$19.2M | ||
Free Cash Flow | -$21.8M | ||
EBIT | -$17.9M | ||
EBITDA | -$17.3M | ||
Net Working Capital | $17.8M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 270 | ||
P/B | 72 | ||
P/E | -21 | ||
PEG | 4 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue